SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Gland Pharma

BSE: 543245 30 Sep 2025
Healthcare
₹ 2006.1
Gland Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Gland Pharma - Share Price & Details

Market Cap
₹32,261
High /Low
2,131 / 1,200
Stock P/E
41.9
Book Value
₹555.0
Dividend Yield
0.92
ROCE
11.9
ROE
₹7.81
Face Value
1.0
PEG Ratio
-2.5
EVEBITDA
₹18.9
Debt
314
CMP / FCF
76.8
Debt to equity
₹0.03
NP Ann
699
High price all time
4,350
Piotroski score
₹5.0
Graham Number
764.0
No. Eq. Shares
16.5
Net CF
₹2,199
Net profit
770
Price to book value
3.53
Interest Coverage
₹25.2
Low price all time
861.0
Industry PE
33.0
Reserves
₹9,134
Free Cash Flow
₹521

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
06 Aug 2025 Motilal Oswal Buy ₹1,954.95 ₹2,340 20.9% moneycontrol View
03 Feb 2025 Motilal Oswal Buy ₹1,520.2 ₹1,840 22.8% moneycontrol View
20 Mar 2024 Motilal Oswal Buy ₹1,702.1 ₹2,240 23.5% moneycontrol View
14 Feb 2024 Motilal Oswal Buy ₹1,953.5 ₹2,240 23.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Gland Pharma Limited10935.762692.5810388.3516.3432,26141.9
AJANTA PHARMA LTD.12491.92549.712085.620.43079933.1
Krishna Institute of Medical S3856.0588.03734.01.472907878.8

Peer Comparison Chart


About Gland Pharma

Gland Pharma Limited, with Security Code 543245, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Gland Pharma Limited's (NSE:GLAND) P/E Is On The Mark

(15 Sep 2025)
With a price-to-earnings (or 'P/E') ratio of 43.2x Gland Pharma Limited ( NSE:GLAND ) may be sending very bearish...
Read more →

Gland Pharma, Siemens Energy among stocks bought & sold by Quant Small Cap Fund in August

(13 Sep 2025)
Quant Small Cap Fund, the largest fund managed by Quant Mutual Fund, has an investment objective to seek to generate capital appreciation...
Read more →

Gland Pharma Ltd spurts 1.55%, rises for third straight session

(08 Sep 2025)
Gland Pharma Ltd is quoting at Rs 1915.3, up 1.55% on the day as on 12:49 IST on the NSE. The stock is up 0.49% in last one year as compared...
Read more →

USFDA approves Gland Pharma Vasopressin in 5% Dextrose RTU Injection

(27 Aug 2025)
This product is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and...
Read more →

Gland Pharma receives USFDA approval for Vasopressin in 5% Dextrose RTU Injection

(26 Aug 2025)
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...
Read more →

Gland Pharma receives FDA approval for Vasopressin in 5% Dextrose RTU Injection

(24 Aug 2025)
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and...
Read more →